Tango Therapeutics (TNGX) director awarded 4,000 RSUs and 25,000 options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Tango Therapeutics director Mace Rothenberg reported equity awards in the form of restricted stock units and stock options. The filing shows a grant of 4,000 shares of Common Stock represented by restricted stock units, plus a stock option for 25,000 shares at an exercise price of $20.2200 per share.
The restricted stock units vest in full on the earlier of June 5, 2027 or the next annual meeting of stockholders, subject to continuous service. The option vests in 12 substantially equal monthly installments over one year starting on July 5, 2026 and expires on June 5, 2036. After the stock grant, Rothenberg holds 41,500 shares of Common Stock directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Rothenberg Mace
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 25,000 | $0.00 | -- |
| Grant/Award | Common Stock | 4,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 25,000 shares (Direct, null);
Common Stock — 41,500 shares (Direct, null)
Footnotes (1)
- These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in their entirety on the earlier of: (i) June 5, 2027 and (ii) the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year, with the first vesting date on July 5, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
Key Figures
Restricted stock units granted: 4,000 shares
Stock options granted: 25,000 options
Option exercise price: $20.2200 per share
+4 more
7 metrics
Restricted stock units granted
4,000 shares
RSUs representing Common Stock granted on June 5, 2026
Stock options granted
25,000 options
Stock Option (Right to Buy) granted on June 5, 2026
Option exercise price
$20.2200 per share
Conversion or exercise price of stock option
Shares held after grant
41,500 shares
Common Stock directly owned after the RSU grant
Option expiration date
June 5, 2036
Expiration of 25,000-share stock option
Option vesting start
July 5, 2026
First monthly vesting date for stock option
RSU vesting date
June 5, 2027 or next annual meeting
RSUs vest in full on the earlier of these dates
Key Terms
restricted stock units, Stock Option (Right to Buy), exercise price, vest, +1 more
5 terms
restricted stock units financial
"These shares are represented by restricted stock units (the "RSUs")."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "20.2200""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"This option shall vest and become exercisable in 12 substantially equal monthly installments"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting of stockholders financial
"on the earlier of: (i) June 5, 2027 and (ii) the date of the next annual meeting of stockholders"
FAQ
What equity awards did Tango Therapeutics (TNGX) director Mace Rothenberg receive?
Mace Rothenberg received 4,000 shares of Common Stock represented by restricted stock units and a stock option for 25,000 shares. The option carries an exercise price of $20.2200 per share and is structured as a time-based vesting award.
How do Mace Rothenberg’s new restricted stock units in Tango Therapeutics (TNGX) vest?
The 4,000 restricted stock units vest in full on the earlier of June 5, 2027 or the date of the next annual meeting of stockholders. Vesting is conditioned on Rothenberg’s continuous service with Tango Therapeutics through the applicable vesting date.
What are the vesting terms of Mace Rothenberg’s new Tango Therapeutics (TNGX) stock option?
The 25,000-share stock option vests in 12 substantially equal monthly installments over one year, starting July 5, 2026. Each installment requires Rothenberg to remain in continuous service with Tango Therapeutics through the applicable monthly vesting date.
What is the exercise price and expiration date of Mace Rothenberg’s Tango Therapeutics stock option?
The stock option has an exercise price of $20.2200 per share and covers 25,000 shares of Common Stock. It is scheduled to expire on June 5, 2036, if not earlier exercised or forfeited under its terms.